Inicio > BIGG > Resultado de la búsqueda

    Resultados: 2

    Deprescribing antihyperglycemic agents in older persons: evidence-based clinical practice guideline

    Farrell, B; Black, C; Thompson, W; McCarthy, L; Rojas-Fernandez, C; Lochnan, H; Shamji, S; Upshur, R; Bouchard, M; Welch, V.
    Can. fam. physician; 63 (11), 2017
    OBJECTIVE: To develop an evidence-based guideline to help clinicians make decisions about when and how to safely taper, stop, or switch antihyperglycemic agents in older adults. METHODS: We focused on the highest level of evidence available and sought input from primary care professionals in guideline de...
    Hiperglucemia/tratamiento farmacológico, Hipoglucemiantes/administración & dosificación, Receptores de Sulfonilureas/efectos de los fármacos, Diabetes Mellitus/tratamiento farmacológico, Toma de Decisiones Clínicas, Hipoglucemiantes/efectos adversos, Deprescripciones, Insulina/administración & dosificación, Insulina/efectos adversos
    Texto completo

    Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline

    Peters, AL; Ahmann, AJ; Battelino, T; Evert, A; Hirsch, IB; Murad, MH; Winter, WE; Wolpert, H.
    J. clin. endocrinol. metab; 101 (11), 2016
    "OBJECTIVE: To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes. PARTICIPANTS: The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical write...
    Glucemia, Terapia Combinada, Diabetes Mellitus Tipo 1, Diabetes Mellitus Tipo 2, Dieta para Diabéticos, Monitoreo de Drogas, Endocrinología, Hiperglucemia, Hipoglucemia, Insulina/uso terapéutico, Sistemas de Infusión de Insulina, Monitoreo Ambulatorio, Educación del Paciente como Asunto, Medicina de Precisión, Diabetes Mellitus Tipo 1/tratamiento farmacológico, Diabetes Mellitus Tipo 2/tratamiento farmacológico, Diabetes Mellitus Tipo 1/terapia, Diabetes Mellitus Tipo 2/terapia, Hipoglucemiantes/uso terapéutico, Hipoglucemiantes/efectos adversos, Insulina/efectos adversos
    Texto completo